Diseases caused by fungi can occur in healthy people, but immunocompromised patients
are the major risk group for invasive fungal infections. Cases of fungal resistance and the …

In recent years, fungal vaccine research emanated significant findings in the field of
antifungal T-cell immunity. The generation of effector T cells is essential to combat many …

Vaccines have been hailed as one of the greatest achievements in the public health during
the past century. The global eradication of Smallpox virus in humans and Rinderpest virus in …

Mycoses are gaining increasing attention in modern medicine because of the increase in
diseases associated with opportunistic fungal infections. Despite the recognized role of the …

Paracoccidioidomycosis (PCM), caused by Paracoccidioides spp, is an important endemic
mycosis in Latin America. There are two recognized Paracoccidioides species, P …

Paracoccidioidomycosis (PCM) is a granulomatous fungal disease caused by the dimorphic
fungal species of Paracoccidioides, which mainly affects the lungs. Modern strategies for the …

Introduction Fungal infections are caused by a broad range of pathogenic fungi that are
found worldwide with different geographic distributions, incidences, and mortality rates …

Dimorphic fungi are agents of systemic mycoses associated with significant morbidity and
frequent lethality in the Americas. Among the pathogenic species are Paracoccidioides …

Current therapies against malignant melanoma generally fail to increase survival in most
patients, and immunotherapy is a promising approach as it could reduce the dosage of toxic …

In impoverished nations, the COVID-19 pandemic has led to a widespread occurrence of
deadly fungal diseases like mucormycosis. The limited availability of effective antifungal …